MALAT1-miR-124-RBG2 axis is involved in growth and invasion of HR-HPV-positive cervical cancer cells

Tumor Biology

Volumn 37, Issue 1, 2016, Pages 633-640

  Liu, Shikai ^a   Song, Lili ^a   Zeng, Saitian ^a   Zhang, Liang ^a  

^a CANGZHOU CENTRAL HOSPITAL   (China)

Author keywords

Cervical cancer; GRB2; HR HPV; MALAT1; miR 124

Indexed keywords

METASTASIS ASSOCIATED LUNG ADENOCARCINOMA TRANSCRIPT 1; UNCLASSIFIED DRUG; UNTRANSLATED RNA; GRB2 PROTEIN, HUMAN; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; LONG UNTRANSLATED RNA; MALAT1 LONG NON-CODING RNA, HUMAN; MESSENGER RNA; MICRORNA; MIRN124 MICRORNA, HUMAN;

ARTICLE; CANCER GROWTH; CARCINOGENESIS; CELL INVASION; CELL VIABILITY; CERVICAL CANCER CELL LINE; CONTROLLED STUDY; CYTOLOGY; ENZYME ACTIVITY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LINEAR REGRESSION ANALYSIS; LUCIFERASE ASSAY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION REGULATION; TUMOR INVASION; UPREGULATION; WART VIRUS; WESTERN BLOTTING; APOPTOSIS; BINDING SITE; CELL MOTION; CELL PROLIFERATION; CHEMISTRY; COMPLICATION; GENE SILENCING; GENETICS; NUCLEOTIDE SEQUENCE; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTION; PATHOLOGY; RNA INTERFERENCE; TUMOR CELL LINE; UTERINE CERVICAL NEOPLASMS; VIROLOGY;

APOPTOSIS; BASE SEQUENCE; BINDING SITES; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; GRB2 ADAPTOR PROTEIN; HUMANS; MICRORNAS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; RNA INTERFERENCE; RNA, LONG NONCODING; RNA, MESSENGER; UTERINE CERVICAL NEOPLASMS;

EID: 84938703126     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-015-3732-4     Document Type: Article

References (27)

1. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014;64:9–29.
2. Munagala R, Kausar H, Munjal C, Gupta RC. Withaferin a induces p53-dependent apoptosis by repression of HPV oncogenes and upregulation of tumor suppressor proteins in human cervical cancer cells. Carcinogenesis. 2011;32:1697–705.
3. Durst M, Gissmann L, Ikenberg H, zur Hausen H. A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci U S A. 1983;80:3812–5.
4. Fu ZC, Wang FM, Cai JM. Gene expression changes in residual advanced cervical cancer after radiotherapy: indicators of poor prognosis and radioresistance? Med Sci Monit Int Med J Exp Clin Res. 2015;21:1276–87.
5. Pan D, Wei K, Ling Y, Su S, Zhu M, Chen G. The prognostic role of ki-67/mib-1 in cervical cancer: a systematic review with meta-analysis. Med Sci Monit Int Med J Exp Clin Res. 2015;21:882–9.
6. Tsai MC, Spitale RC, Chang HY. Long intergenic noncoding rnas: new links in cancer progression. Cancer Res. 2011;71:3–7.
7. Kornienko AE, Guenzl PM, Barlow DP, Pauler FM. Gene regulation by the act of long non-coding rna transcription. BMC Biol. 2013;11:59.
8. Xu S, Jin C, Shen X, Ding F, Zhu J, Fu G. MicroRNAs as potential novel therapeutic targets and tools for regulating paracrine function of endothelial progenitor cells. Med Sci Monit Int Med J Exp Clin Res. 2012;18:HY27–31.
9. Jiang Y, Li Y, Fang S, Jiang B, Qin C, Xie P, et al. The role of MALAT1 correlates with HPV in cervical cancer. Oncol Lett. 2014;7:2135–41.
10. Guo F, Li Y, Liu Y, Wang J, Li Y, Li G. Inhibition of metastasis-associated lung adenocarcinoma transcript 1 in caski human cervical cancer cells suppresses cell proliferation and invasion. Acta Biochim Biophys Sin. 2010;42:224–9.
11. Furuta M, Kozaki KI, Tanaka S, Arii S, Imoto I, Inazawa J. Mir-124 and mir-203 are epigenetically silenced tumor-suppressive micrornas in hepatocellular carcinoma. Carcinogenesis. 2010;31:766–76.
12. Xia J, Wu Z, Yu C, He W, Zheng H, He Y, et al. Mir-124 inhibits cell proliferation in gastric cancer through down-regulation of sphk1. J Pathol. 2012;227:470–80.
13. Wan HY, Li QQ, Zhang Y, Tian W, Li YN, Liu M, et al. MiR-124 represses vasculogenic mimicry and cell motility by targeting amotL1 in cervical cancer cells. Cancer Lett. 2014;355:148–58.
14. Wu H, Zhang J. MiR-124 rs531564 polymorphism influences genetic susceptibility to cervical cancer. Int J Clin Exp Med. 2014;7:5847–51.
15. Wilting SM, van Boerdonk RA, Henken FE, Meijer CJ, Diosdado B, Meijer GA, et al. Methylation-mediated silencing and tumour suppressive function of hsa-miR-124 in cervical cancer. Mol Cancer. 2010;9:167.
16. Liu S, Song L, Zhang L, Zeng S, Gao F. MiR-21 modulates resistance of HR-HPV positive cervical cancer cells to radiation through targeting LATS1. Biochem Biophys Res Commun. 2015;459:679–85.
17. Li JH, Liu S, Zhou H, Qu LH, Yang JH. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 2014;42:D92–7.
18. Gutschner T, Hammerle M, Diederichs S. Malat1—a paradigm for long noncoding RNA function in cancer. J Mol Med. 2013;91:791–801.
19. Hirata H, Hinoda Y, Shahryari V, Deng G, Nakajima K, Tabatabai ZL, et al. Long noncoding RNA MALAT1 promotes aggressive renal cell carcinoma through Ezh2 and interacts with miR-205. Cancer Res. 2015;75:1322–31.
20. Shen L, Chen L, Wang Y, Jiang X, Xia H, Zhuang Z. Long noncoding RNA MALAT1 promotes brain metastasis by inducing epithelial-mesenchymal transition in lung cancer. J Neuro-Oncol. 2015;121:101–8.
21. Yang MH, Hu ZY, Xu C, Xie LY, Wang XY, Chen SY, et al. MALAT1 promotes colorectal cancer cell proliferation/migration/invasion via PRKA kinase anchor protein 9. Biochim Biophys Acta. 1852;2015:166–74.
22. Cesana M, Cacchiarelli D, Legnini I, Santini T, Sthandier O, Chinappi M, et al. A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell. 2011;147:358–69.
23. Hansen TB, Jensen TI, Clausen BH, Bramsen JB, Finsen B, Damgaard CK, et al. Natural RNA circles function as efficient microRNA sponges. Nature. 2013;495:384–8.
24. Wong KY, So CC, Loong F, Chung LP, Lam WW, Liang R, et al. Epigenetic inactivation of the miR-124-1 in haematological malignancies. PLoS ONE. 2011;6, e19027.
25. Sastry L, Cao T, King CR. Multiple Grb2-protein complexes in human cancer cells. Int J Cancer J Int Cancer. 1997;70:208–13.
26. Spangle JM, Munger K. The HPV16 E6 oncoprotein causes prolonged receptor protein tyrosine kinase signaling and enhances internalization of phosphorylated receptor species. PLoS Pathog. 2013;9, e1003237.
27. Belleudi F, Leone L, Purpura V, Cannella F, Scrofani C, Torrisi MR. HPV16 E5 affects the KGFR/FGFR2b-mediated epithelial growth through alteration of the receptor expression, signaling and endocytic traffic. Oncogene. 2011;30:4963–76.